½ÃÀ庸°í¼­
»óǰÄÚµå
1596754

½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå : Á¦Ç° À¯Çü, Åõ¿© °æ·Î, À¯Åë ä³Î, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Steroid Injections Market by Product Type (Cortisone, Hydrocortisone, Methylprednisolone), Administration Route (Epidural, Intra-Articular, Intramuscular), Distribution Channel, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀåÀº 2023³â¿¡ 38¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 42¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 13.54%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 92¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

½ºÅ×·ÎÀ̵å ÁÖ»ç´Â ¿°Áõ°ú ÅëÁõÀ» ÁÙÀ̱â À§ÇØ ºÎ½ÅÇÇÁú ½ºÅ×·ÎÀ̵带 ½ÅüÀÇ ¿°Áõ°ú ÅëÁõ ºÎÀ§¿¡ Á÷Á¢ Åõ¿©ÇÏ´Â Ä¡·á¹ýÀÔ´Ï´Ù. °üÀý¿°, °Ç¿°, Ȱ¾×³¶¿°°ú °°Àº Áõ»ó¿¡ ÇʼöÀûÀ̸ç, ´Ù¸¥ Ä¡·á¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ȯÀÚ¿¡°Ô´Â Áֻ簡 Å« ¿ÏÈ­¸¦ °¡Á®¿À°í À̵¿¼ºÀ» °³¼±Çϱ⠶§¹®¿¡ ÇʼöÀûÀÔ´Ï´Ù. ½ºÅ×·ÎÀ̵å ÁÖ»ç´Â º´¿ø ¿Ü·¡, Ŭ¸®´Ð, °³ÀΠŬ¸®´Ð µî ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÃÖÁ¾ »ç¿ëÀÚ´Â Á¤Çü¿Ü°ú Àü¹®ÀǺÎÅÍ ½ºÆ÷Ã÷ ÀÇ»ç±îÁö ´Ù¾çÇÕ´Ï´Ù. ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀåÀº ±Ù°ñ°Ý°è ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀü°ú »õ·Î¿î ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÀÇ °³¹ßÀº ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê°ú R&D ÅõÀÚ¸¦ ÅëÇØ ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ¸é ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ºÎÀÛ¿ë °¡´É¼º, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ½Åü ÀçȰ ¹× °æ±¸ ¾à¹°°ú °°Àº ´ëü ¿ä¹ýÀÇ °¡¿ë¼º µîÀÇ Á¦¾àÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀ» ÃËÁøÇϱâ À§ÇØ ±â¾÷µéÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â ÁÖ»çÁ¦ Á¦Çü °³¼±¿¡ ÁýÁßÇϰí, ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÏ´Â Â÷¼¼´ë Àü´Þ ±â¼úÀ» ¸ð»öÇØ¾ß ÇÕ´Ï´Ù. ½ÅÈï±¹ ½ÃÀåÀº ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®Ãß¾îÁ® ÀÖ°í ÷´Ü Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀáÀçÀûÀÎ ¼ºÀå ÀáÀç·ÂÀÌ ÀÖÀ¸¸ç, ÀÌ Áö¿ª¿¡ ´ëÇÑ ÅõÀÚ°¡ Àü·«ÀûÀ¸·Î ÀÌ·ç¾îÁú ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸ÇÏ°í ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀåÀÇ Æ¯¼ºÀº È¿°úÀûÀÎ ÅëÁõ °ü¸® ¹× ¿°Áõ Á¶Àý ¿ä¹ý¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¿¡ ÈûÀÔ¾î °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å°ú ÇÔ²² ȯÀÚÀÇ ¿ä±¸¿Í ÀÇ·á Æ®·»µå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ÀÌÇØ´Â ÀÌ·¯ÇÑ °æÀïÀûÀÎ ½ÃÀå »óȲ¿¡¼­ È®Àå ¹× ÀûÀÀÀ» À§ÇÑ Å« ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 38¾ï ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 42¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 92¾ï 5,000¸¸ ´Þ·¯
CAGR(%) 13.54%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Á¤Çü¿Ü°ú Áúȯ ¹ß»ý¿¡ µû¸¥ ³ëÀÎ Àα¸ Áõ°¡
    • ÀþÀº Ãþ¿¡¼­ º¸µðºôµùÀÇ ÀαⰡ ³ô¾ÆÁü
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ºÅ×·ÎÀ̵å ÁÖ»ç »ç¿ë¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦
  • ½ÃÀå ±âȸ
    • ¼ºÇü¿Ü°ú ¼ö¼ú¿¡ ´ëÇÑ ¸Å·Â Áõ°¡
    • ½ºÅ×·ÎÀ̵å ÁÖ»çÀÇ ¼Ò°³ ¹× ½ÂÀÎ
  • ½ÃÀå °úÁ¦
    • ½ºÅ×·ÎÀÌµå ¼·Ãë¿¡ µû¸¥ À¯ÇØÇÑ ºÎÀÛ¿ë

Portre's Five Forces: ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå °ø·«À» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ·Â ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸®´Â ¹æ¹ý

½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå : Á¦Ç° À¯Çüº°

  • Cortisone
  • Hydrocortisone
  • Methylprednisolone
  • Triamcinolone

Á¦7Àå ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå : Åõ¿© °æ·Îº°

  • °æ¸·¿Ü ¸¶Ãë
  • °üÀý³»
  • ±ÙÀ°³»
  • Á¤¸Æ³»

Á¦8Àå ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå : À¯Åë ä³Îº°

  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • Àü¹® Ŭ¸®´Ð

Á¦9Àå ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå : ¿ëµµº°

  • °­Á÷¼º ôÃß¿°
  • ¿äÅë
  • Ȱ¾×Æ÷¿°
  • ¾Ï
  • Åëdz
  • °ñ°üÀý¿°
  • °Ç¼±¼º °üÀý¿°
  • ·ù¸¶Æ¼½º °üÀý¿°

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ºÅ×·ÎÀ̵å ÁÖ»ç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Actiza Pharmaceutical Private Limited
  • AdvaCare Pharma
  • ANI Pharmaceuticals, Inc.,
  • Bristol-Myers Squibb Company
  • Farmabios GmbH
  • Flagship Biotech International Private Limited.
  • Flexion Therapeutics Inc.
  • GSK plc
  • Health Biotech Limited
  • Intrapharm Laboratories
  • Merck & Co., Inc.
  • Merit Healthcare International Inc.
  • Mylan N.V.
  • Novartis AG
  • Perrigo Company plc
LSH

The Steroid Injections Market was valued at USD 3.80 billion in 2023, expected to reach USD 4.29 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 9.25 billion by 2030.

Steroid injections are a medical treatment involving the administration of corticosteroids directly into inflamed or painful areas in the body to reduce inflammation and pain. Essential for conditions like arthritis, tendonitis, and bursitis, these injections provide significant relief and improve mobility, making them necessary for patients unresponsive to other treatments. Steroid injections are applied in various medical settings, including hospital outpatient departments, clinics, and private medical practices, with end-users ranging from orthopedic specialists to sports medicine practitioners. The market for steroid injections is witnessing growth driven by the increasing prevalence of musculoskeletal disorders, the rising geriatric population, and growing demand for minimally invasive procedures. Technological advancements in drug delivery systems and the development of novel corticosteroids present lucrative opportunities for market players. Addressing these through strategic partnerships and R&D investments can enhance market presence. However, the market faces limitations such as the potential for side effects, stringent regulatory requirements, and the availability of alternative therapies like physical rehabilitation and oral medications, which can hinder growth. To drive innovation, companies should focus on improving the formulation of injectable drugs for better patient outcomes and explore next-generation delivery technologies that minimize adverse effects. Markets in emerging economies offer potential growth due to increasing healthcare infrastructure and rising awareness of advanced therapeutic solutions, suggesting investment in these regions would be strategic. Despite challenges, the nature of the steroid injection market remains robust, sustained by continuous demand for effective pain management and inflammation control therapies. A comprehensive understanding of patient needs and healthcare trends, alongside technological innovation, can offer substantial opportunities for expansion and adaptation in this competitive market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 3.80 billion
Estimated Year [2024] USD 4.29 billion
Forecast Year [2030] USD 9.25 billion
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Steroid Injections Market

The Steroid Injections Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing geriatric population along with occurrences of orthopedic disorders
    • Popularity of bodybuilding among young people
  • Market Restraints
    • Stringent regulation for steroid injection usage
  • Market Opportunities
    • Growing attraction towards plastic surgeries
    • Introduction and approval of the steroid injections
  • Market Challenges
    • Harmful side effects associated with the consumption of steroids

Porter's Five Forces: A Strategic Tool for Navigating the Steroid Injections Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Steroid Injections Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Steroid Injections Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Steroid Injections Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Steroid Injections Market

A detailed market share analysis in the Steroid Injections Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Steroid Injections Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Steroid Injections Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Steroid Injections Market

A strategic analysis of the Steroid Injections Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Steroid Injections Market, highlighting leading vendors and their innovative profiles. These include Actiza Pharmaceutical Private Limited, AdvaCare Pharma, ANI Pharmaceuticals, Inc.,, Bristol-Myers Squibb Company, Farmabios GmbH, Flagship Biotech International Private Limited., Flexion Therapeutics Inc., GSK plc, Health Biotech Limited, Intrapharm Laboratories, Merck & Co., Inc., Merit Healthcare International Inc., Mylan N.V., Novartis AG, and Perrigo Company plc.

Market Segmentation & Coverage

This research report categorizes the Steroid Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cortisone, Hydrocortisone, Methylprednisolone, and Triamcinolone.
  • Based on Administration Route, market is studied across Epidural, Intra-Articular, Intramuscular, and Intravenous.
  • Based on Distribution Channel, market is studied across Hospital Pharmacy, Retail Pharmacy, and Specialty Clinics.
  • Based on Application, market is studied across Ankylosing Spondylitis, Back pain, Bursitis, Cancer, Gout, Osteoarthritis, Psoriatic Arthritis, and Rheumatoid Arthritis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing geriatric population along with occurrences of orthopedic disorders
      • 5.1.1.2. Popularity of bodybuilding among young people
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulation for steroid injection usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing attraction towards plastic surgeries
      • 5.1.3.2. Introduction and approval of the steroid injections
    • 5.1.4. Challenges
      • 5.1.4.1. Harmful side effects associated with the consumption of steroids
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Steroid Injections Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cortisone
  • 6.3. Hydrocortisone
  • 6.4. Methylprednisolone
  • 6.5. Triamcinolone

7. Steroid Injections Market, by Administration Route

  • 7.1. Introduction
  • 7.2. Epidural
  • 7.3. Intra-Articular
  • 7.4. Intramuscular
  • 7.5. Intravenous

8. Steroid Injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Retail Pharmacy
  • 8.4. Specialty Clinics

9. Steroid Injections Market, by Application

  • 9.1. Introduction
  • 9.2. Ankylosing Spondylitis
  • 9.3. Back pain
  • 9.4. Bursitis
  • 9.5. Cancer
  • 9.6. Gout
  • 9.7. Osteoarthritis
  • 9.8. Psoriatic Arthritis
  • 9.9. Rheumatoid Arthritis

10. Americas Steroid Injections Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Steroid Injections Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Steroid Injections Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Actiza Pharmaceutical Private Limited
  • 2. AdvaCare Pharma
  • 3. ANI Pharmaceuticals, Inc.,
  • 4. Bristol-Myers Squibb Company
  • 5. Farmabios GmbH
  • 6. Flagship Biotech International Private Limited.
  • 7. Flexion Therapeutics Inc.
  • 8. GSK plc
  • 9. Health Biotech Limited
  • 10. Intrapharm Laboratories
  • 11. Merck & Co., Inc.
  • 12. Merit Healthcare International Inc.
  • 13. Mylan N.V.
  • 14. Novartis AG
  • 15. Perrigo Company plc
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦